Exhibitors
|
Exhibitors
FUJIFILM Toyama Chemical offers integrated drug discovery services for infectious disease. We have been engaged in small molecule drug discovery in infectious diseases for decades and has a proven track record of discovering important drugs for the treatment of infectious diseases. This is owing to our competitive advantage based on our strengths in drug discovery: insight, originality, and unconventional idea. Our drug discovery experts embody our track record and strengths can accelerate your drug discovery through our integrated drug discovery services.
Gennova Biopharmaceuticals Ltd., headquartered in Pune, India, is a biotechnology company dedicated to the research and development, production, and commercialization of biotherapeutics and vaccines to address life-threatening diseases. Gennova is transforming healthcare by creating efficient and effective solutions for manufacturing and successfully commercializing bio-therapeutics across cardiovascular, neurology, nephrology, ophthalmology, and oncology segments. Gennova has developed world's first thermostable self-amplifying mRNA-based platform technology for COVID-19 vaccines, including India's first mRNA vaccine, GEMCOVAC®-19. Gennova along with other partners in USA and Japan are engaged with GHIT for development of live attenuated vaccine for leishmaniasis and diagnostic leishmanin antigen skin test.
|
|  |
MMV is a Swiss-based not-for-profit organization working to deliver a portfolio of accessible medicines with the power to treat, prevent and eliminate malaria. Born in 1999, out of a need for greater health equity, we close critical gaps in research, development and access – working “end-to-end” to expand the use of existing antimalarials and innovate new compounds to protect public health. This starts with women and children.
Nanotis is a University of Tokyo affiliated start-up developing next-generation digital testing technologies covering a wide range of virus inspections including COVID-19 and flu. Nanotis successfully developed a technology called "Nucleic Acid Navigated Optically Traceable Immuno‐Sensing (NANOTIS method)," which will achieve simple, quick and affordable saliva-based testing with excellent accuracy. With the NANOTIS method, test results will be digitally processed in a single step, and it has the potential to become a core technology for efficient infection control.
NEC is a global technology company that was founded in Japan over 120 years ago. Today, NEC has a broad portfolio of solutions from submarine cables to satellites, and from smart city infrastructure to world leading biometrics and AI. NEC co-creates solutions with UN and other international organizations, committed to "Digitalization for LEAVE NO ONE BEHIND." Showcasing cutting edge technologies and model cases in the field of Renewable Energy, Agriculture, Healthcare and AI, NEC aspires to create a more inclusive and sustainable future.
PHC Corporation is a global leader in healthcare and life sciences, offering advanced medical equipment, laboratory solutions, and diagnostics. Its flagship PATHFAST system provides rapid, precise point-of-care testing, including reagents for tuberculosis diagnosis. This innovation supports early detection and treatment, enhancing patient care. Serving hospitals, research institutions, and clinics worldwide, PHC is committed to advancing healthcare through cutting-edge technology and sustainable practices.
Remedy and Company Corporation is a Health Tech Platformer providing Clinical Research Support for clients across the globe. We are a member of GHIT and have aligned our objectives to further the 100 Days Mission on behalf of Japan and the APAC countries. We specialize in field work for the Global South which need further support for neglected tropical diseases (NTD), Malaria, Tuberculosis and AMR. As part of our innovative task force, we are pursuing to be the first clinical research center for Controlled Human Infection Models in Asia.
|
|---|
|
|---|
| |
|---|
|
|